Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-29
DOI
10.1002/med.21654
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in Aptamer Discovery and Applications
- (2019) Yang Zhang et al. MOLECULES
- Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses
- (2019) Kenya Tamada et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- The resident macrophages in murine pancreatic islets are constantly probing their local environment, capturing beta cell granules and blood particles
- (2018) Bernd H. Zinselmeyer et al. DIABETOLOGIA
- RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity
- (2018) Andisheh Abedini et al. JOURNAL OF CLINICAL INVESTIGATION
- Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
- (2018) Kailash Prasad MOLECULAR AND CELLULAR BIOCHEMISTRY
- Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
- (2018) Carlos Rosales Frontiers in Physiology
- Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
- (2018) Nicholas J Thomas et al. Lancet Diabetes & Endocrinology
- Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside
- (2018) Wook-Jin Chae et al. Frontiers in Immunology
- S100B Suppression Alters Polarization of Infiltrating Myeloid-Derived Cells in Gliomas and Inhibits Tumor Growth
- (2018) Hang Gao et al. CANCER LETTERS
- Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis
- (2018) Raelene J. Pickering et al. JOURNAL OF CLINICAL INVESTIGATION
- The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
- (2018) Tommi Vatanen et al. NATURE
- Temporal development of the gut microbiome in early childhood from the TEDDY study
- (2018) Christopher J. Stewart et al. NATURE
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice
- (2017) Nobutaka Nakamara et al. MOLECULAR MEDICINE
- S100A7: from mechanism to cancer therapy
- (2017) L Padilla et al. ONCOGENE
- Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial
- (2017) Helena Elding Larsson et al. PEDIATRIC DIABETES
- A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
- (2017) Gagan Priya et al. Diabetes Therapy
- On type 1 diabetes mellitus pathogenesis
- (2017) Stavroula A Paschou et al. Endocrine Connections
- A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
- (2017) Gagan Priya et al. Diabetes Therapy
- Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury
- (2017) Hisatake Matsumoto et al. Scientific Reports
- Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial
- (2016) Barbora de Courten et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
- (2016) Mingzhan Xue et al. DIABETES
- Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study
- (2016) Kendra Vehik et al. DIABETES CARE
- Life expectancy of type 1 diabetic patients during 1997–2010: a national Australian registry-based cohort study
- (2016) Lili Huo et al. DIABETOLOGIA
- The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus
- (2016) Sean P. Durning et al. JOURNAL OF IMMUNOLOGY
- Environmental risk factors for type 1 diabetes
- (2016) Marian Rewers et al. LANCET
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
- (2016) Michaele B. Manigrasso et al. Scientific Reports
- Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States
- (2015) D. C. Brennan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Global epidemiology of type 1 diabetes in young adults and adults: a systematic review
- (2015) Paula A Diaz-Valencia et al. BMC PUBLIC HEALTH
- Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat
- (2015) Kathleen E. Davis et al. BRITISH JOURNAL OF NUTRITION
- Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
- (2015) Richard A. Insel et al. DIABETES CARE
- Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
- (2015) Kellee M. Miller et al. DIABETES CARE
- Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
- (2015) J. A. McKnight et al. DIABETIC MEDICINE
- The pancreas anatomy conditions the origin and properties of resident macrophages
- (2015) Boris Calderon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FO048RAGE−DNA APTAMER IMPROVES ALDOSTERON-INDUCED RENAL INJURY POSSIBLY VIA INHIBITION OF RAC1−MR AXIS IN MICE WITH HYPERTENSIVE NEPHROPATHY
- (2015) Kensei Taguchi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells
- (2015) Anthony N. Vomund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A run on the biobank
- (2015) John S. Kaddis et al. Current Opinion in Endocrinology Diabetes and Obesity
- Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway
- (2015) Xian Jin et al. Biomed Research International
- Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
- (2015) K. D. Rainsford et al. INFLAMMOPHARMACOLOGY
- The formin DIAPH1 (mDia1) regulates megakaryocyte proplatelet formation by remodeling the actin and microtubule cytoskeletons
- (2014) J. Pan et al. BLOOD
- Generation of Functional Human Pancreatic β Cells In Vitro
- (2014) Felicia W. Pagliuca et al. CELL
- Role of B Lymphocytes in the Pathogenesis of Type 1 Diabetes
- (2014) Rochelle M. Hinman et al. Current Diabetes Reports
- Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated With -Cell Autoimmunity in Patients With Type 1 Diabetes
- (2014) Y. Wang et al. DIABETES
- Circulating Concentrations of Soluble Receptor for AGE Are Associated With Age andAGERGene Polymorphisms in Children With Newly Diagnosed Type 1 Diabetes
- (2014) Kirsi M. Salonen et al. DIABETES CARE
- Macrophages and -cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes
- (2014) J. Diana et al. EMBO Molecular Medicine
- Elevated Levels of Serum IL-12 and IL-18 are Associated with Lower Frequencies of CD4+CD25highFOXP3+ Regulatory T cells in Young Patients with Type 1 Diabetes
- (2014) Monika Ryba-Stanisławowska et al. INFLAMMATION
- B Lymphocyte Depletion by CD20 Monoclonal Antibody Prevents Diabetes in Nonobese Diabetic Mice despite Isotype-Specific Differences in Fc R Effector Functions
- (2014) Y. Xiu et al. JOURNAL OF IMMUNOLOGY
- High Mobility Group Box 1 Protein Binding to Lipopolysaccharide Facilitates Transfer of Lipopolysaccharide to CD14 and Enhances Lipopolysaccharide-Mediated TNF- Production in Human Monocytes
- (2014) J. H. Youn et al. JOURNAL OF IMMUNOLOGY
- Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
- (2014) Alireza Rezania et al. NATURE BIOTECHNOLOGY
- Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease
- (2014) D. Galasko et al. NEUROLOGY
- S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer
- (2014) S Dakhel et al. Oncogenesis
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Soluble Receptor for Advanced Glycation End Products Alleviates Nephritis in (NZB/NZW)F1 Mice
- (2013) Sang-Won Lee et al. ARTHRITIS AND RHEUMATISM
- Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes
- (2013) Keiko Fujisawa et al. ATHEROSCLEROSIS
- Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification
- (2013) Marcelle GA van Eupen et al. Cardiovascular Diabetology
- CD4+CD45RA−FoxP3highactivated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes
- (2013) F. Haseda et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
- (2013) Yusuke Kaida et al. DIABETES
- Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
- (2013) N. N. Pejnovic et al. DIABETES
- Reduced Blood Leukocyte and Neutrophil Numbers in the Pathogenesis of Type 1 Diabetes
- (2013) M. Harsunen et al. HORMONE AND METABOLIC RESEARCH
- Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization
- (2013) ENDY WIDYA PUTRANTO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- RAGE regulation and signaling in inflammation and beyond
- (2013) Katrin Kierdorf et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Type 1 diabetes
- (2013) Mark A Atkinson et al. LANCET
- Breakdown in Peripheral Tolerance in Type 1 Diabetes in Mice and Humans
- (2013) L. T. Jeker et al. Cold Spring Harbor Perspectives in Medicine
- Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: Preliminary results
- (2013) Xiang Hu MEDICAL SCIENCE MONITOR
- Dendritic Cell Subsets in Type 1 Diabetes: Friend or Foe?
- (2013) Penelope A. Morel Frontiers in Immunology
- Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19+, CD3+ and Mac-1+ cells in lymphoid organs and peritoneal cavity
- (2012) Mikael Brisslert et al. CELL AND TISSUE RESEARCH
- Formin mDia1 Mediates Vascular Remodeling via Integration of Oxidative and Signal Transduction Pathways
- (2012) Fatouma Touré et al. CIRCULATION RESEARCH
- S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
- (2012) T. Arumugam et al. CLINICAL CANCER RESEARCH
- Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
- (2012) Huriya Beyan et al. DIABETES
- Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age
- (2012) V. Chiavaroli et al. DIABETES CARE
- The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trial
- (2012) D. A. Fraser et al. DIABETES CARE
- Primary and secondary prevention of Type 1 diabetes
- (2012) J. S. Skyler DIABETIC MEDICINE
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
- (2012) Ken T. Coppieters et al. JOURNAL OF EXPERIMENTAL MEDICINE
- RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses
- (2012) Eitan M. Akirav et al. PLoS One
- Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
- (2012) Alaa Alkhalaf et al. PLoS One
- T-Cell Tolerance: Central and Peripheral
- (2012) Y. Xing et al. Cold Spring Harbor Perspectives in Biology
- Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
- (2011) Ravichandran Ramasamy et al. Annals of the New York Academy of Sciences
- Genetics of Type 1 Diabetes
- (2011) A. K. Steck et al. CLINICAL CHEMISTRY
- RAGE biology, atherosclerosis and diabetes
- (2011) Drazenka Pongrac Barlovic et al. CLINICAL SCIENCE
- Advanced Glycation End Products Are Direct Modulators of -Cell Function
- (2011) M. T. Coughlan et al. DIABETES
- Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study
- (2011) J. W. Nin et al. DIABETES CARE
- Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes: Potential role of AGER1 and SIRT1
- (2011) J. Uribarri et al. DIABETES CARE
- Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes
- (2011) J. M. Forbes et al. DIABETOLOGIA
- S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release
- (2011) Roberta Bianchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
- (2011) Y. Yamamoto et al. JOURNAL OF IMMUNOLOGY
- Association Between Serum Levels of the Soluble Receptor (sRAGE) for Advanced Glycation Endproducts (AGEs) and their Receptor (RAGE) in Peripheral Blood Mononuclear Cells of Children with Type 1 Diabetes Mellitus
- (2011) A. Dettoraki et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Beneficial Effects of Ethyl Pyruvate through Inhibiting High-Mobility Group Box 1 Expression and TLR4/NF-κB Pathway after Traumatic Brain Injury in the Rat
- (2011) Xingfen Su et al. MEDIATORS OF INFLAMMATION
- TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding
- (2011) Masakiyo Sakaguchi et al. PLoS One
- Metabolic Regulation in Progression to Autoimmune Diabetes
- (2011) Marko Sysi-Aho et al. PLoS Computational Biology
- Aldose Reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats
- (2010) Kellie McCormick Hallam et al. AGING CELL
- PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
- (2010) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases
- (2010) Inès Birlouez-Aragon et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Glycation in diabetic nephropathy
- (2010) Josephine M. Forbes et al. AMINO ACIDS
- Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
- (2010) M. Peakman et al. DIABETES
- Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes
- (2010) Johanna W.M. Nin et al. DIABETES
- A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
- (2010) A. Alkhalaf et al. DIABETES CARE
- Reduced soluble receptor for advanced glycation end-products in COPD
- (2010) D. J. Smith et al. EUROPEAN RESPIRATORY JOURNAL
- Prediction and Pathogenesis in Type 1 Diabetes
- (2010) Anette-G. Ziegler et al. IMMUNITY
- Phenothiazines inhibit S100A4 function by inducing protein oligomerization
- (2010) V. N. Malashkevich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase I Clinical Studies of the Advanced Glycation End-product (AGE)-Breaker TRC4186
- (2009) Kumar P. Chandra et al. CLINICAL DRUG INVESTIGATION
- Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
- (2009) D. Yao et al. DIABETES
- Prevention of Type 1 Diabetes
- (2009) Diane K. Wherrett et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer
- (2009) Yi Luo et al. EUROPEAN JOURNAL OF CANCER
- C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus
- (2009) Carlos E. B. Couri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1
- (2009) Helen Vlassara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
- (2009) Ravichandran Ramasamy et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective Effect of HMGB1 A Box on Organ Injury of Acute Pancreatitis in Mice
- (2009) Hai Yuan et al. PANCREAS
- Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
- (2009) Per Björk et al. PLOS BIOLOGY
- A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice
- (2008) Susanne Bro et al. ATHEROSCLEROSIS
- Binding of S100 proteins to RAGE: An update
- (2008) Estelle Leclerc et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Analysis of islet inflammation in human type 1 diabetes
- (2008) A. Willcox et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
- (2008) P. Fiorina et al. DIABETES
- Viral Trigger for Type 1 Diabetes: Pros and Cons
- (2008) C. M. Filippi et al. DIABETES
- High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study
- (2008) N. Rabbani et al. DIABETOLOGIA
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
- (2008) Barry I. Hudson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
- (2008) Evis Harja et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification, classification, and expression of RAGE gene splice variants
- (2007) Barry I. Hudson et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started